… bleeding with potent antiplatelet agents after an acute coronary event: a comparison of ticagrelor and clopidogrel in 5116 consecutive patients in clinical practice

L Mullen, MN Meah, A Elamin, S Aggarwal… - … of the American Heart …, 2021 - Am Heart Assoc
… recognized end points for myocardial infarction and bleeding, … from clopidogrel paired with
aspirin to ticagrelor with aspirin … consented patients, as is standard in randomized controlled …

… aspirin and clopidogrel versus aspirin monotherapy in mild-to-moderate acute ischemic stroke according to the risk of recurrent stroke: an analysis of 15 000 patients …

HL Lee, JT Kim, JS Lee, MS Park, KH Choi… - … Quality and Outcomes, 2020 - Am Heart Assoc
… (ischemic and hemorrhagic), myocardial infarction (MI), and all-cause … In the present study,
45% of the patients with mild-to-… Additional randomized controlled trials are warranted to …

… versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised …

BK Koo, J Kang, KW Park, TM Rhee, HM Yang… - The Lancet, 2021 - thelancet.com
… ), clinical presentation (acute myocardial infarction or not and acute coronary syndrome or
not), … between both groups (852 [31·4%] vs 882 [32·3%]). Detailed clinical diagnosis of these …

… -based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized …

S Park, SW Rha, BG Choi, W Kim, WG Choi… - American Heart …, 2023 - Elsevier
patients into 3 groups: DAT (aspirin and clopidogrel for 12 … In total, 852 enrolled patients
(90%) were followed up … that the addition of cilostazol to DAT may not provide additional benefits …

[HTML][HTML] Dual antiplatelet therapy in patients with high cardiovascular risk

C Espinoza, D Mukherjee - Heart International, 2021 - ncbi.nlm.nih.gov
… , non-fatal stroke, myocardial infarction (MI) or major bleeding … patients with a history of
ischaemic stroke were randomized … stroke/TIA, short-course clopidogrel plus aspirin for 21 days …

Efficacy and safety of clopidogrel, prasugrel and ticagrelor in ACS patients treated with PCI: a propensity score analysis of the RENAMI and BleeMACS registries

M Peyracchia, A Saglietto, C Biole… - American Journal of …, 2020 - Springer
… in terms of recurrent myocardial infarction (MI) and bleedings. This … aspirin in addition to
clopidogrel, ticagrelor, or prasugrel. … analyzed, was in accord with a recent randomized trial [15]. …

CYP2C19 Genotype Prevalence and Association With Recurrent Myocardial Infarction in British–South Asians Treated With Clopidogrel

EF Magavern, B Jacobs, H Warren, G Finocchiaro… - JACC: Advances, 2023 - jacc.org
… with an acute myocardial infarction were prescribed clopidogrel. Poor metabolizers were
significantly more likely to have a recurrent myocardial infarction (OR: 3.1; P = 0.019). …

Dual antiplatelet therapies and causes in minor stroke or transient ischemic attack: a prespecified analysis in the CHANCE-2 Trial

X Xie, J Jing, X Meng, S Claiborne Johnston, PM Bath… - Stroke, 2023 - Am Heart Assoc
… of ticagrelor-aspirin versus clopidogrel-aspirin in transient … In contrast to myocardial infarction,
which is almost always … was generated centrally using a random-permuted fixed-size block …

[HTML][HTML] Aspirin at 120: Retiring, recombining, or repurposing?

C Patrono, B Rocca - Research and Practice in Thrombosis and …, 2021 - Elsevier
… a randomized controlled trial (RCT) of 16 000 patients with … (the number of Thrombolysis in
Myocardial Infarction [TIMI] major … of colorectal adenomas in 852 patients aged <75 years with …

Dual antiplatelet therapy before coronary artery bypass grafting in patients with myocardial infarction: a prospective cohort study

R Sadeghi, M Haji Aghajani, R Miri, N Kachoueian… - BMC surgery, 2021 - Springer
… that DAPT with aspirin and clopidogrel before CABG in patients with MI has no effect on …
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised